Abstract: The present patent application provides an oral nicotine-substituted cytisine atomized liquid and its preparation method. The oral nicotine-substituted cytisine atomized liquid includes the following components in mass percentage per 1 L of the oral atomized liquid: 0.1-10% of tobacco, 0.3-15% of cocoa extract, 0.1-0.9% of cytisine, 0.1-0.5% of TWEEN 80 and 75-90% of primer. The liquid can be obtained through the steps of weighing tobacco into an extraction tank, filtering the extract to obtain the filtrate, adding cocoa extract, cytisine and primer to the filtrate and mixing evenly.

Abstract: An electronic cigarette comprises nicotine without harmful tar. The cigarette includes a shell, a cell, nicotine solution, control circuit, and an electro-thermal vaporization nozzle installed in the air suction end of the shell. The advantages of the present invention are smoking without tar, reducing the risk of cancer, the user still gets a smoking experience, the cigarette is not lit, and there is no fire danger.

Abstract: An electronic cigarette comprises nicotine without harmful tar. The cigarette includes a shell, a cell, nicotine solution, control circuit, and an electro-thermal vaporization nozzle installed in the air suction end of the shell. The advantages of the present invention are smoking without tar, reducing the risk of cancer, the user still gets a smoking experience, the cigarette is not lit, and there is no fire danger.

Abstract: An electronic substitute cigarette includes a cigarette rod(10) and a simulated cigarette mouthpiece(20). Said cigarette rod(10) includes a power source and an electronic circuit. Said simulated cigarette mouthpiece(20) includes a simulated filter(25), a liquid storage chamber(28) and an atomizer(22). The atomizer(22) is connected with the power output terminal of the cigarette rod(10). A columnar alloy sponge is mounted within the atomizer(22). The simulated filter(25) includes a main body(252) and a through hole(254). The liquid chamber(28) mounted into one end of the through hole(254) includes a container(281) having at least one protrusions(284) and a sealing membrane(30).

Abstract: An electronic cigarette includes a shell and a mouthpiece. The external wall of the shell has an air inlet. An atomizer and a liquid-supply are in contact with each other. The air inlet, atomizer, an aerosol passage, and a mouthpiece are sequentially interconnected.

Abstract: The invention relates to heat not burn products comprising an encapsulated aerosol generating agent, the encapsulation having the effect of controlling the release of the agent during use of the heat not burn product. The encapsulation will control the timing of the release of the aerosol generating agent during the use of the heat not burn product, to allow greater control of the puff yield. In the case of some aerosol generating agents, the encapsulation may also increase the stability of the agent and/or prevent its migration within the product.

Abstract: A method of forming a liquor comprising tobacco solutes, the method comprising extracting tobacco solutes from tobacco by flowing an extraction solvent through tobacco to form a tobacco solutes-rich extraction solvent and a tobacco solutes-poor tobacco, and forming tobacco solutes-rich liquor by flowing the tobacco solutes-rich extraction solvent through an entrapment solvent, wherein the tobacco solutes comprise nicotine and at least one tobacco flavor compound and/or tobacco aroma compound and the liquor comprises the tobacco solutes dissolved in the entrapment solvent. A preferred extraction solvent comprises a supercritical fluid. Also provided are cigarettes and cigarette components comprising extracted tobacco solutes such as flavor compounds, aroma compounds and nicotine. Further, tobacco from which aroma compounds and/or nicotine have been extracted can be used in cigarettes.

Abstract: An electronic cigarette includes a battery assembly, an atomizer assembly and a cigarette bottle assembly. An external thread electrode is located in one end of battery assembly. An internal thread electrode is located in one end of atomizer assembly. The battery assembly and the atomizer assembly are connected by the screwthread electrode. The cigarette bottle assembly is inserted into the other end of the atomizer assembly and both form a cigarette type or cigar type body.

Abstract: A power supply device of an electronic cigarette is disclosed, the device comprising a battery and a control board installed inside a battery sleeve; the power supply device further comprises electrode connectors provided at one end of the battery for connecting an atomizer as a load into the circuit loop of the electronic cigarette, wherein the electrode connectors comprises a negative pole connector coupled to one end of the battery sleeve; a positive pole connector sit inside the negative pole connector; an insulation ring being provided between the negative pole connector and the positive pole connector to achieve electric isolation; the controlling board being provided at the other end of the battery inside the battery sleeve; the controlling board is integrated thereon a controller, a LED light and an airflow switch; the controller connecting the load connected between the positive pole connector and the negative pole connector into the power supply loop of the battery and controlling on/off of the LED

Abstract: A composition containing therapeutic agents and/or breath freshening agents for use in the oral cavity is disclosed. The carrier comprises water-soluble polymers in combination with certain ingredients and provides a therapeutic and/or cosmetic effect. The film is coated and dried utilizing existing coating technology and exhibits instant wettability followed by rapid dissolution/disintegration upon administration in the oral cavity.

Abstract: Methods of use of a nasal insert to support smoking cessation, and methods of use of a nasal insert to reduce or eliminate snoring, and a method of use of a nasal insert to reduce the severity or to eliminate obstructive sleep apnea, and a method of use of a nasal insert to gain smoother, easier breathing through the nose. The nasal insert comprises a body having an inner surface which defines an air passageway surrounded by an outer surface of soft, flexible material. The nasal insert body can have a first portion and a second portion where the outer surface of said nasal insert body is configured to the nasal cavity.

Abstract: Tobacco products comprising smokeless tobacco products and active ingredients, including those that antagonize nicotinic acetylcholine receptors, the TRPV1 channel, and/or the TRPA1 channel are disclosed. Nicotine replacement therapies comprising active ingredients, including those that antagonize nicotinic acetylcholine receptors, the TRPV1 channel, and/or the TRPA1 channel. The active ingredient may reduce or eliminate sensory irritation arising due to use of the product. Analgesic compositions comprising active ingredients. Methods of reducing taste and sensory irritation by employing an active ingredient.

Abstract: The invention relates generally to a system or kit that delivers nicotine to target the regions of the respiratory tract to achieve the maximum impact on craving with a minimum number of unwanted sensations. More specifically, the invention relates to pulmonary administration of nicotine from nicotine inhalation systems that target delivery to the deep lung, minimizing deposition in the upper and central airways.

Abstract: The claimed subject matter provides a control component that regulates output of an electronic vaporizer used to simulate smoking. The control component manages power to a heating element. A power detect component collects a parameter of the heating element to determine actual power output thereof. The control component dynamically adjusts the power source based on the actual power output.

Abstract: A nicotine delivery product comprising the reaction product of a nicotine/cation exchange resin complex and an organic polyol; and a method for preparing it comprising (a) mixing an aqueous suspension of a nicotine/cation exchange resin complex with an organic polyol or an aqueous solution thereof, and (b) removing water from the mixture to produce said nicotine delivery product. The nicotine delivery product has a nicotine release rate of at least 80% over a 10 minute period. It is particularly suited for use in smoking substitution devices delivering nicotine such as chewing gum, patches, lozenges, melting tablets and tablets for chewing.

Abstract: The present disclosure generally relates to electronic cigarette components. As will be disclosed, an electronic cigarette may have a flexible conduit, texture layer, and outer wrapper. The texture layer may be constructed of synthetic or organic material that, together with the outer wrapper will simulate the texture of the tobacco rod and cigarette paper of a traditional cigarette.

Abstract: A chewing gum tablet including at least two cohered chewing gum modules, the tableted chewing gum being formed by compression of chewing gum granules, at least one of the chewing gum modules including gum base granules, the gum base granules including an elastomer system, the chewing gum tablet including an elastomer system in an amount of at least 10% by weight of the tablet. A compressed chewing gum tablet has been obtained featuring extremely impressing abilities of incorporating well-defined amounts of chewing gum ingredients combined with acceptable rheological properties of the compete tablet.

Abstract: The present disclosure generally relates to an aroma pack for electronic cigarettes. The aroma pack comprises an aromatic insert, which is infused with a tobacco-like aroma, located within a housing positioned inside the aroma pack. The aromatic insert emits the scent of tobacco when the top cover of the pack is opened.

Abstract: An electronic cigarette including an atomizer, a cartridge, a mouthpiece, a power switch, and an electronic cigarette refilling apparatus for use therein is disclosed. A method of dispensing a liquid into an electronic cigarette and a method of inhaling a vapor from an electronic cigarette are also disclosed.

Abstract: A device which facilitates the absorption of nicotine in order to reduce the incidence of tobacco smoking is disclosed. The device includes a tube defining an interior space. The tube has a first end with an opening and a second end. An inhalable, flowable liquid or gel composition is disposed in the interior space of the tube. The composition may include water, at least one vitamin, a flavoring agent, and nicotine. The flavoring agent may include an intense sweetener such as sucralose, and a natural or artificial fruit flavor. A user inhales on the first end of the tube of the device as a substitute oral activity to tobacco smoking and thereby ingests a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

Abstract: The current invention discloses an inexpensive, easy to use anti-smoking device. The device has an elongated strip having a center portion, a first arm, and second arm along the elongated strip, and a center piece that is attached to the center portion of the elongated strip. The first arm and second arm of the elongated strip can be wrapped around the center piece to attach to the center piece, forming two loops that allow two fingers of the person trying to quit smoking to engage the anti-smoking device. The center piece is to be stuck between two fingers, preferably the fingers the person trying to quit smoking normally uses to clutch cigarettes. The center piece is sized so that two fingers cannot be held close enough to clutch a cigarette.

Abstract: An atomizing electronic cigarette has an atomizing core component and a liquid storage component, including an electric heater. The electric heater may have a through hole aligned with a channel passing through the liquid storage component. The cigarette can heat and uniformly vaporize liquid from the liquid storage component, with the user inhaling the vaporized liquid. The vapor generated by the atomizing process may be cooled as it flows through the channel.

Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.

Abstract: A tobacco solution atomizing device for electronic cigarette is disclosed the device comprises an atomizer installed in a fixing sleeve; a suction nozzle component and electrode connectors coupled on respective ends of the fixing sleeve, wherein the electrode connectors comprises a positive electrode connector and a negative electrode connector; the atomizer comprising a glass fiber tube, a glass fiber yarn, a heating coil, a cotton cloth layer and a synthetic fiber layer, wherein the glass fiber yarn is insert into the heating coil which is then located inside the glass fiber tube; the ends of the glass fiber silk and two wires which are used to electronically connect the heating coil to the positive and negative electrode connectors extends outward through the glass fiber tube; the cotton cloth layer enwraps the outside wall of the glass fiber tube and reveal ends of the glass fiber yarn are pressed tightly between the cotton cloth layer and the glass fiber tube; a synthetic fiber layer is filled within the

Abstract: A pouched tobacco product includes a lined pouch material of a web and a water-soluble liner adjacent the web and a tobacco component contained within the lined pouch material. The water-soluble liner is interposed between the web and the tobacco component. The liner preferably reduces staining of the web by the tobacco component. Additionally, the liner may include a flavorant.

Abstract: A device which facilitates the absorption of nicotine in order to reduce the incidence of tobacco smoking is disclosed. The device includes a tube defining an interior space. The tube has a first end with an opening and a second end. An inhalable, flowable liquid or gel composition is disposed in the interior space of the tube. The composition may include water, at least one vitamin, a flavoring agent, and nicotine. The flavoring agent may include an intense sweetener such as sucralose, and a natural or artificial fruit flavor. A user inhales on the first end of the tube of the device as a substitute oral activity to tobacco smoking and thereby ingests a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

Abstract: A chewing gum comprising at least one active pharmaceutical ingredient (API) with a core onto which is applied at least one inner polymer film coating and thereafter onto which is applied at least one outer hard coating. A preferred API is nicotine. Flavoring agents may be incorporated in the core, in the at least one inner polymer film coating and/or in the at least one outer hard coating. The gums formed exhibit a long lasting effect of flavoring agent(s) and result in the domination of flavoring agents in the coating(s) over flavoring agent(s) in the core, thereby (a) avoiding problems of chemical or pharmaceutical incompatibility between an API in the core and flavoring agent(s) in the coating(s) and (b) achieving an increased control of the release of the API and of non-active excipients.

Abstract: A device for simulating a chemosensation of smoking includes an outer layer, a porous medium and a chemesthetic agent. The porous medium is disposed within the outer layer. The chemesthetic agent is disposed within the porous medium and activates a TRP channel.

Abstract: A non-heating flavor inhaler (1) comprises a suction holder (2) including an upstream section (10) extending from a front end thereof to a partition (4) in the suction holder (2), and a downstream section (14) extending from the front end thereof to a mouth end in the suction holder (2), the downstream section (14) having a front passage extending along the upstream section (10), an ambient air intake (12) provided in a circumferential wall of the suction holder (2) to connect the upstream section (10) to the outside, and a pouch (30) for releasing a tobacco flavor, the pouch (3) being located on the boundary between the upstream section (10) and the downstream section (14) and extending along a longitudinal axis of the suction holder (2).

Abstract: A sheath for a smoking article, such as a filter cigarette, including an exterior sheath (5) that provides a ventilation structure which has a reduced possibility of occlusion, and which also prevents a reduction in filter efficacy when the strength of the draw on the smoking article by the consumer is increased, for example in order to overcome the effects of dilution of the smoke flow with ambient air. The sheath may be manufactured as an independent entity and then fitted to prefabricated smoking articles, or alternatively may be constructed as an integral part of the smoking article.

Abstract: The present disclosure provides for an apparatus and related method for controlling the rate of nicotine delivery into systemic circulation of a subject. The method comprises transdermally administering nicotine at a topical administration site of a subject; achieving a steady state plasma concentration of nicotine in the subject; and activating a temperature modification apparatus over the topical administration site after achieving the steady state. The temperature modification apparatus can be configured to generate heat for a predetermined period of time. Further, about 5 to about 30 minutes following activation of the temperature modification apparatus, the subject's nicotine plasma concentration increases by at least about 5% over the subject's steady state nicotine plasma concentration.

Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.

Abstract: Provided is an oral pouch flavor product with a fibrous flavored wrapper that encloses an inner filling material. Preferably, the fibrous flavored wrapper includes embedded flavorants. The fibrous flavored wrapper may also include a softening agent, colorants, and/or browning inhibitors. The inner material may include non-tobacco, plant material fibers and preferably has a low moisture content so as to prevent the need for preservatives or refrigeration.

Abstract: An alkaloid composition for an inhaler contains a solvent and at least about 25 wt. % anatabine based on the total alkaloid weight of the composition. The alkaloid composition may be contained in a refilling cartridge for an inhaler, or in a container as part of a kit for refilling an inhaler. The alkaloid compositions disclosed herein feature a balanced form of alkaloids to provide an attractive alternative to smoking tobacco, in which nicotine makes up about 90 wt. % of the total alkaloid content. The alkaloid compositions are characterized by a significant quantity of anatabine, which has lower toxicity than other alkaloids such as nicotine. The alkaloid compositions enable individuals to experience the pleasure-enhancing attributes of conventional cigarette smoking, while avoiding exposure to combusted materials and other potentially hazardous components present in tobacco.

Abstract: A smokeless tobacco analogue material comprises comminuted sunflower seed hulls that are processed to be tasteless and to have a consistency and feel similar or complementary to a smokeless tobacco product. The analogue material can be mixed with a smokeless tobacco product to dilute and eventually eliminate the smokeless tobacco being used. Such mixing and progressive dilution of the smokeless tobacco proportion being used progressively dilutes the smokeless tobacco product taste and the nicotine concentration being consumed by a user. Other flavorings can also be added to the tasteless analogue material if desired.

Abstract: An aerosol generator device has an elongate body with an interior passageway extending longitudinally to its mouth end. The device receives an interchangeable, pressurized canister charged with a nicotine containing liquid that is discharged in a metered dose on manual actuation of a button member that causes a valve in the canister to open and discharge through a discharge tube. A sleeve releasably couples the canister to the body. The button member is slidably mounted on the body for reciprocal movement along a trigger axis Y-Y? extending transversely of the longitudinal axis X-X? of the device, and has a manually depressible surface portion and a camming surface portion that drives a slidable nozzle member to press the discharge tube inwardly of the canister to open its valve and release liquid into the nozzle member. Nozzle forms an aerosol from the liquid, which is delivered to the consumer through outlets in the mouth end of the device.

Abstract: An electronic cigarette including an elongated housing that has a mouthpiece with an aerosol outlet, and an atomizer disposed within an atomizing chamber. The atomizer selectively generates an aerosol of the liquid in response to suction pressure at the aerosol outlet. The atomizing chamber has an air inlet, an atomizer outlet coupled to the aerosol outlet, and a first wick aperture. A liquid reservoir is disposed within the elongated housing, which is sealably separated from the atomizing chamber. A wick disposed through the first wick aperture between the liquid reservoir and the atomizing chamber and it is configured to transfer the liquid by capillarity from the liquid reservoir to the atomizer.

Abstract: A smoking cessation tobacco pipe helps smokers to fully and directly realize the harm of tobacco to a human body when they are smoking and give up smoking and publicize smoking cessation. The tobacco pipe is a transparency which is assembled with a top cover part (2) integrated with a smoke-inlet pipe (3) and a smoke-outlet pipe (4), a box body part (1), a bottom cover part (6) and a smoking pipe part (5), wherein the smoke-outlet pipe (4) is connected with the smoking pipe part (5), and when in use the tobacco is placed at the opening of the smoke-inlet pipe (3). A series of tiny holes are provided on the smog route from the smoke-inlet pipe (3) to the smoke-outlet pipe (4), where the tiny holes are arranged and assembled to form warning characters or patterns, which warn that smoking is harmful to health. The characters and patterns are strengthened due to the adhesive attachment of smoke.

Abstract: An electronic cigarette includes a shell and a mouthpiece. The external wall of the shell has an air inlet. An atomizer and a liquid-supply are in contact with each other. The air inlet, atomizer, an aerosol passage, and a mouthpiece are sequentially interconnected.

Abstract: A composition intended to be employed for therapeutic purposes incorporates an active ingredient (e.g., a source of nicotine) and at a non-active ingredient that is carried by a porous substrate. The non-active ingredient can be a substance that has the capability of affecting the pH of the biological system to which it is applied (e.g., basic substance and/or buffering agent is sorbed onto the porous carrier, so as to be in intimate contact with that carrier). Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) and nicotine polacrilex. The basic substance can be sodium carbonate, and the porous substrate can be microcrystalline cellulose. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and can be used as a nicotine replacement therapy.

Abstract: An electronic cigarette includes a shell and a mouthpiece. The external wall of the shell has an air inlet. An atomizer and a liquid-supply are in contact with each other. The air inlet, atomizer, an aerosol passage, and a mouthpiece are sequentially interconnected.

Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.

Abstract: The invention relates to a device for smoking cessation, consisting of a cylindrical sleeve (2), the inside diameter dI of which is dimensioned such that the sleeve can be placed positively and completely on a cigarette (1) so that the cigarette (1) projects beyond both free ends (22) of the sleeve (2), and the sleeve jacket (3) has a thickness SQ of at least 1 mm. The invention further relates to a use of such a device as a cigarette holder.

Abstract: A device for and a method form a barrier comprised of a distributed zone of fluid in a filter of a smoking article. The device includes a container for a fluid which forms a wet impact barrier when inserted into the smoking article, and a delivery feature communicating between the container and an outlet of the delivery feature, for transfer of the fluid to filter of the smoking article. The delivery feature is formed by a tube of significantly lesser diameter than the diameter of the smoking article. The combination of container and delivery feature provides for placement of a defined quantity of fluid at a predetermined location within the smoking article, such as by injection through a side wall of the filter in the vicinity of the filter/tobacco boundary.

Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.

Abstract: A container for holding and dispensing a liquid and/or dissolved active substance, for example a pharmaceutical or cosmetic active substance, has at least one dispensing organ (5) for dispensing, preferably in a portioned manner, the one active substance. Provision is also made for at least two holding chambers (9, 11) separated from one another, at least one of which contains the one active substance and at least one of which contains an at least largely active-substance-free liquid and/or a further active substance differing from the one active substance, wherein the dispensing organ is connected to the at least one chamber containing the active substance for dispensing purposes.

Abstract: A chewing gum comprising at least one active pharmaceutical ingredient (API) with a core onto which is applied at least one inner polymer film coating and thereafter onto which is applied at least one outer hard coating. A preferred API is nicotine. Flavoring agents may be incorporated in the core, in the at least one inner polymer film coating and/or in the at least one outer hard coating. The gums formed exhibit a long lasting effect of flavoring agent(s) and result in the domination of flavoring agents in the coating(s) over flavoring agent(s) in the core, thereby (a) avoiding problems of chemical or pharmaceutical incompatibility between an API in the core and flavoring agent(s) in the coating(s) and (b) achieving an increased control of the release of the API and of non-active excipients.

Abstract: The cigarette case smoking cessation device only allows lid opening and therefore cigarette access at times set by the adjustable timer. The device thereby allows a smoker to predetermine cigarette access in designing a period for weaning off of cigarettes, of just reducing smoking itself. The device provides automatic unlocking at the set intervals, thereby allowing lid opening. The device provides both audio and vibratory alert of cigarette access. The device provides a gasket between case and lid so that cigarettes stay fresh. The charge port is an important feature in assuring battery charge and therefore long-life operation between charges. The thin walled device is compact and only slightly larger than a cigarette pack itself.

Abstract: This invention relates to a device which functions as a cigarette holder and can reduce the intake of cigarette smoke into the lungs of a user. The holder is substantially tubular and has a first end (14) for mounting a cigarette, the first end having an annular wall (12) with an internal dimension larger than the diameter of the cigarette, the annular wall carrying a plurality of inwardly-directed longitudinal ribs (20) adapted to engage and support the cigarette. Between the ribs are passageways which can allow the flow of air along the outside of the cigarette into the mouth of the user, so that the volume of smoke breathed in by the user can be reduced.

Abstract: The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.